Nath Bio-Genes Statements
NA
Nath Bio-Genes Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
747.76
100
50.797
-21.05
696.96
121.1
—
0
417.24
78.4
614.53
113.3
82.43
7.8
-39.102
-2.5
0.374
0
43.702
5.3
13.808
1.4
64.382
6.1
4.93
13.966
2 578.49
100
1 269.92
18.8
1 308.57
81.2
—
0
795.28
41.8
901.63
62.1
406.94
19.2
-52.01
-10.8
1.765
0.3
356.69
8.6
5.654
1.5
351.05
7.1
18.375
19.057
702.88
100
-205.56
-67.009
908.43
167
—
0
126.09
13.6
829.6
160.5
78.835
6.5
-44.922
-3.4
3.165
0.6
37.078
3.7
9.309
0.5
27.869
3.2
1.466
19.007
2 310.8
100
1 083.6
22.7
1 227.2
77.3
97.5
13.5
737.7
41.9
848.7
58.5
378.5
18.8
-56.3
-12.7
2.4
0.9
324.5
7
2.3
0.3
322.3
6.8
16.95
19.05
488.7
100
-71.3
-52.7
560
152.7
—
0
742.9
251.2
729.8
234.7
-169.8
-82
-51.7
-9.08
10
2.6
-1 099.2
-414.7
35.6
12.7
-1 134.8
-427.4
-59.72
19
2 295
100
1 172
16.2
1 122.9
83.8
84.2
11.3
513.8
42.7
611.7
58.7
511.3
25.2
-54.4
-18.7
8.5
2.6
465.4
9
3.9
0.7
461.4
8.3
24.28
18.95
910.5
100
240.9
23.1
669.5
76.9
—
0
519.3
72.4
509.1
58.1
160.4
18.8
-48.3
-5
8.2
-0.2
120.3
13.6
6.4
0.6
113.9
13
5.99
19
2 165.1
100
1 007
12.7
1 158.1
87.3
116.5
22.4
549.6
41.6
679.6
67
478.6
20.3
-39.9
-8.6
8.5
1.9
447.1
13.6
4.4
0.6
442.7
12.9
23.3
19
932.1
100
311.6
34.1
620.5
65.9
—
0
507.9
65.8
503.5
55.2
117
10.6
-33.2
-2.8
8.7
0.8
92.4
8.6
-23
-4.09
115.3
12.7
6.07
19
1 866.8
100
848
4.8
1 018.9
95.2
102.7
25.6
493.6
44.7
603.5
72
415.4
23.3
-32.2
-7
9.5
1.5
392.8
17.8
3.2
0.5
389.5
17.3
20.49
19